Lifevantage Corp (LFVN)
Data as of , from SEC Form 4 filings.
See up to 3 months of LFVN. The 7-day demo opens the 1M and 3M ranges and puts LFVN on your watchlist.
Start 7-day demoLatest LFVN insider trades
About Lifevantage Corp (LFVN)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product. Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.
- LEHI, UT
- 223
- 1997
- XNAS
LFVN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 976 | $6K |
| Open-market sale | 2 | 9,001 | $56K |
| Grant or award | 8 | 1,503,354 | |
LFVN insider transactions (Form 4)
4066 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Common Stock | 32,850 | $0.00 | - | ||
| Grant or award | Performance Restricted Stock Units | 49,275 | $0.00 | - | ||
| Grant or award | Common Stock | 35,749 | $0.00 | - | ||
| Grant or award | Performance Restricted Stock Units | 53,623 | $0.00 | - | ||
| Terrence Moorehead - Officer | Grant or award | Common Stock | 193,237 | $0.00 | - | |
| Terrence Moorehead - Officer | Grant or award | Performance Restricted Stock Units | 289,855 | $0.00 | - | |
| Tax withholding / forfeiture | Common Stock | 460 | $6.24 | $3K | ||
| Tax withholding / forfeiture | Common Stock | 637 | $6.24 | $4K | ||
| Darwin Lewis - Director | Open-market purchase | Common Stock | 976 | $6.22 | $6K | |
| Tax withholding / forfeiture | Common Stock | 1,869 | $6.37 | $12K | ||
| Tax withholding / forfeiture | Common Stock | 2,254 | $6.37 | $14K | ||
| Open-market sale | Common Stock | 100 | $6.41 | $641 | ||
| Open-market sale | Common Stock | 8,901 | $6.18 footnote F1 | $55K | ||
| ||||||
| Terrence Moorehead - Officer | Grant or award | Common Stock | 308,642 | $0.00 | - | |
| Terrence Moorehead - Officer | Grant or award | Performance Restricted Stock Units | 540,123 | $0.00 | - | |
| Tax withholding / forfeiture | Common Stock | 1,361 | $6.25 | $9K | ||
| Tax withholding / forfeiture | Common Stock | 1,717 | $6.25 | $11K | ||
| Alissa Neufeld - Officer | Tax withholding / forfeiture | Common Stock | 1,342 | $6.25 | $8K | |
| Darwin Lewis | Open-market purchase | Common Stock | 705 | $8.60 | $6K | |
| Michael A. Beindorff | Open-market sale | Common Stock | 10,000 | $8.55 footnote F1 | $85K | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 8,180 | $4.20 | $34K | ||
| Alissa Neufeld - Officer | Tax withholding / forfeiture | Common Stock | 1,446 | $4.20 | $6K | |
| Tax withholding / forfeiture | Common Stock | 1,527 | $4.20 | $6K | ||
| Tax withholding / forfeiture | Common Stock | 1,928 | $4.20 | $8K | ||
| Darwin Lewis | Open-market purchase | Common Stock | 1,055 | $5.23 | $6K | |
| Judd Dayton - Director | Open-market purchase | Common Stock | 4,600 | $4.58 footnote F1 | $21K | |
| Judd Dayton - Director | Open-market purchase | Common Stock | 18,097 | $4.63 footnote F2 | $84K | |
| Judd Dayton - Director | Open-market purchase | Common Stock | 10,500 | $4.53 footnote F3 | $48K | |
| ||||||
| Darwin Lewis - Director | Open-market purchase | Common Stock | 3,955 | $5.22 footnote F1 | $21K | |
| ||||||
| Michael A. Beindorff - Director | Open-market sale | Common Stock | 12,607 | $6.42 footnote F1 | $81K | |
| ||||||
| Rajendran Anbalagan - Director | Grant or award | Common Stock | 13,531 footnote F1 | $7.76 footnote F2 | $105K | |
| ||||||
| Cynthia Latham - Director | Grant or award | Common Stock | 13,531 footnote F1 | $7.76 footnote F2 | $105K | |
| ||||||
| Raymond B. Greer - Director | Grant or award | Common Stock | 13,531 footnote F1 | $7.76 footnote F2 | $105K | |
| ||||||
| Michael A. Beindorff - Director | Open-market sale | Common Stock | 35,000 footnote F3 | $6.92 footnote F4 | $242K | |
| Michael A. Beindorff - Director | Open-market sale | Common Stock | 1,000 | $7.33 | $7K | |
| Michael A. Beindorff - Director | Grant or award | Common Stock | 13,531 footnote F1 | $7.76 footnote F2 | $105K | |
| ||||||
| Judd Dayton - Director | Grant or award | Common Stock | 13,531 footnote F1 | $7.76 footnote F2 | $105K | |
| ||||||
| Darwin Lewis - Director | Grant or award | Common Stock | 13,531 footnote F1 | $7.76 footnote F2 | $105K | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 1,835 | $9.56 | $18K | ||
| Tax withholding / forfeiture | Common Stock | 1,720 | $9.56 | $16K | ||
Recent LFVN Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
LFVN insider trading FAQ
What is the latest insider trade for LFVN?
Lifevantage Corp (LFVN) had 9 insider filings in the last 90 days, with the most recent on 2026-10-09. The full record for LFVN runs to 66 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LFVN stock?
1 insider purchase of LFVN was filed in the last 90 days, totaling $6K.
How many insiders are selling LFVN stock?
2 insider sales of LFVN were filed in the last 90 days, totaling $56K.
Where can I see LFVN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LFVN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kristen Cunningham view on EDGAR
- - Carl Aure view on EDGAR
- - Terrence Moorehead view on EDGAR
- - Carl Aure view on EDGAR
- - Kristen Cunningham view on EDGAR
- - Darwin Lewis view on EDGAR
- - Carl Aure view on EDGAR
- - Kristen Cunningham view on EDGAR
- - Terrence Moorehead view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where LFVN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LFVN with a 7-day demo
- LFVN on your watchlist
- Every LFVN Form 4 filing on record
- Up to 3 months of LFVN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive